Operating Company Healthcare

Velocity Clinical Research

Durham, North Carolina, United States

Velocity Clinical Research is an organization of fully integrated clinical research sites. It partners with pharmaceutical and biotechnology companies to provide unified research site solutions—including patients, investigators, and research staff—supported by a technology hub, for clinical trials across the U.S. and Europe.

Focus Areas
Fully integrated clinical research site network, Clinical trial site management (SMO), Patient recruitment and trial execution

Tracked deals

9

9 tracked deals across 2020-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

5 addon · 4 buyout

Velocity Clinical Research Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Velocity Clinical Research. 2 2020 3 2021 3 2022 1 2023

Supporting Data

Recent Transactions

  • Velocity Clinical Research Acquires Impact Research Institute and Liver Institute Northwest Clinical Trials Unit
    October 25, 2023
    Buyer
    Velocity Clinical Research
    Target
    Impact Research Institute, Liver Institute Northwest (clinical trials unit)
    Industry
    Healthcare Services
    Location
    United States
    Type
    Addon

    Velocity Clinical Research, a Durham, North Carolina–based integrated clinical site network, acquired Impact Research Institute (Waco, TX) and the clinical trials unit of Liver Institute Northwest (Seattle, WA). The deal expands Velocity's MASH/MASLD (metabolic dysfunction-associated steatohepatitis/steatotic liver disease) capabilities, adds two KOLs (Dr. Kris Kowdley and Dr. Nadege Gunn) and integrates two additional hepatology research sites into its global network.

  • Velocity Clinical Research Acquires Meridian Clinical Research
    December 15, 2022
    Buyer
    Velocity Clinical Research, GHO Capital Partners LLP
    Target
    Meridian Clinical Research
    Industry
    Healthcare Services
    Location
    Nebraska, United States
    Type
    Addon

    Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.

  • Velocity Clinical Research Acquires MedPharmics
    September 7, 2022
    Buyer
    Velocity Clinical Research, GHO Capital Partners LLP
    Target
    MedPharmics
    Industry
    Healthcare Services
    Location
    Louisiana, United States
    Type
    Addon

    Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.

  • Velocity Clinical Research Acquires TrierHealth
    February 22, 2022
    Buyer
    Velocity Clinical Research
    Target
    TrierHealth
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    Durham-based Velocity Clinical Research acquired digital clinical trials platform TrierHealth, bringing its founder Raghu Punnamraju into Velocity as Chief Technology Officer. The acquisition adds Hyderabad-based R&D talent and patient-engagement technology to accelerate Velocity’s move toward decentralized and hybrid clinical trials.

  • Velocity Clinical Research Acquires VitaLink Research and National Research Institute
    September 22, 2021
    Buyer
    Velocity Clinical Research
    Target
    VitaLink Research, National Research Institute (NRI)
    Industry
    Healthcare Services
    Location
    United States
    Type
    Buyout

    Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.

  • Main Street Exits NRI Clinical Research and SambaSafety; Buyers Velocity Clinical Research and Stone Point Capital
    September 21, 2021
    Buyer
    Velocity Clinical Research, Stone Point Capital
    Target
    NRI Clinical Research, LLC, SambaSafety (Safety Holdings, Inc.)
    Seller
    Main Street Capital Corporation
    Industry
    Healthcare Services
    Location
    United States
    Type
    Buyout

    Main Street Capital Corporation fully exited its investments in NRI Clinical Research, LLC (sold to sponsor-backed Velocity Clinical Research) and realized additional gains on the sale of its remaining equity interest in SambaSafety following Stone Point Capital's acquisition. Main Street reported realized gains of approximately $8.8 million on NRI and $4.5 million on SambaSafety as part of these portfolio exits.

  • Velocity Clinical Research Acquires Downtown Women's Health Care (DWHC) and Riverside Clinical Research
    March 17, 2021
    Buyer
    Velocity Clinical Research
    Target
    Downtown Women's Health Care (DWHC), Riverside Clinical Research
    Seller
    Arthur Waldbaum, MD, Trish Hardee, Bruce Hardee
    Industry
    Healthcare Services
    Location
    United States
    Type
    Buyout

    Velocity Clinical Research, a Durham, North Carolina-based integrated clinical site operator, acquired two U.S. clinical research sites: Downtown Women's Health Care (Denver, CO) and Riverside Clinical Research (northeast Florida). The deals expand Velocity's site footprint to 16 locations, broaden its therapeutic capabilities into renal and hepatic research, and support efforts to diversify patient recruitment for clinical trials.

  • Velocity Clinical Research Acquires eStudySite Inc
    November 11, 2020
    Buyer
    Velocity Clinical Research
    Target
    eStudySite Inc
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Addon

    Velocity Clinical Research has acquired eStudySite Inc, adding two San Diego locations (La Mesa and Chula Vista) to its U.S. site portfolio and bringing the company's total to 14 sites. The deal is intended to improve recruitment of volunteers from minority communities and expand Velocity's infectious disease and vaccine trial capabilities.

  • Velocity Clinical Research Acquires Omega Medical Research and Buynak Clinical Research
    June 16, 2020
    Buyer
    Velocity Clinical Research
    Target
    Omega Medical Research, Buynak Clinical Research
    Industry
    Healthcare Services
    Location
    United States
    Type
    Addon

    Durham-based Velocity Clinical Research has acquired Omega Medical Research (Providence, Rhode Island) and Buynak Clinical Research (Valparaiso, Indiana), expanding its multi-site footprint to 12 sites across nine states. The deals, together with a strategic partnership with Elite Research Network, are intended to boost Velocity’s capacity for vaccine and COVID-19 treatment trials while adding geographic and therapeutic diversity.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 9 tracked deals by Velocity Clinical Research. Acquisitions in California 2 tracked deals by Velocity Clinical Research. Acquisitions in Louisiana 1 tracked deal by Velocity Clinical Research. Acquisitions in Nebraska 1 tracked deal by Velocity Clinical Research.

Related articles

Selling a company? Get in front of buyers like Velocity Clinical Research

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →